Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies.

IF 6.7
Oncolytic Virotherapy Pub Date : 2018-04-30 eCollection Date: 2018-01-01 DOI:10.2147/OV.S150637
Chun Xu, Annika Verena Goß, Carmen Dorneburg, Klaus-Michael Debatin, Jiwu Wei, Christian Beltinger
{"title":"Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies.","authors":"Chun Xu,&nbsp;Annika Verena Goß,&nbsp;Carmen Dorneburg,&nbsp;Klaus-Michael Debatin,&nbsp;Jiwu Wei,&nbsp;Christian Beltinger","doi":"10.2147/OV.S150637","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Attenuated oncolytic measles virus (OMV) is a promising antitumor agent in early-phase clinical trials. However, pre-existing immunity against measles might be a hurdle for OMV therapy.</p><p><strong>Methods: </strong>OMV was inactivated with short-wavelength ultraviolet light (UV-C). Loss of replication and oncolytic activity of UV-inactivated OMV were confirmed by tissue culture infective dose 50 (TCID<sub>50</sub>) assay using Vero cells and by flow cytometry using Jurkat cells. An enzyme-linked immunosorbent assay was performed to verify that UV-inactivated OMV remained antigenic. Different doses of UV-inactivated OMV were pre-cultured in media supplemented with measles immune serum. The mixture was transferred to Jurkat cells and active OMV was added. Active OMV-induced death of Jurkat cells was monitored by flow cytometry.</p><p><strong>Results: </strong>UV-inactivation abrogates OMV replication while maintaining its antigenicity. UV-inactivated OMV sequesters pre-existing anti-MV antibodies in Jurkat cell culture, thereby protecting active OMV from neutralization and preserving oncolytic activity.</p><p><strong>Conclusion: </strong>We prove the principle that a non-replicating OMV can serve as a \"decoy\" for neutralizing anti-MV antibodies, thereby allowing antitumor activity of OMV.</p>","PeriodicalId":19491,"journal":{"name":"Oncolytic Virotherapy","volume":null,"pages":null},"PeriodicalIF":6.7000,"publicationDate":"2018-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/OV.S150637","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncolytic Virotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OV.S150637","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Background: Attenuated oncolytic measles virus (OMV) is a promising antitumor agent in early-phase clinical trials. However, pre-existing immunity against measles might be a hurdle for OMV therapy.

Methods: OMV was inactivated with short-wavelength ultraviolet light (UV-C). Loss of replication and oncolytic activity of UV-inactivated OMV were confirmed by tissue culture infective dose 50 (TCID50) assay using Vero cells and by flow cytometry using Jurkat cells. An enzyme-linked immunosorbent assay was performed to verify that UV-inactivated OMV remained antigenic. Different doses of UV-inactivated OMV were pre-cultured in media supplemented with measles immune serum. The mixture was transferred to Jurkat cells and active OMV was added. Active OMV-induced death of Jurkat cells was monitored by flow cytometry.

Results: UV-inactivation abrogates OMV replication while maintaining its antigenicity. UV-inactivated OMV sequesters pre-existing anti-MV antibodies in Jurkat cell culture, thereby protecting active OMV from neutralization and preserving oncolytic activity.

Conclusion: We prove the principle that a non-replicating OMV can serve as a "decoy" for neutralizing anti-MV antibodies, thereby allowing antitumor activity of OMV.

Abstract Image

Abstract Image

Abstract Image

诱骗病毒保护溶瘤性麻疹病毒免受中和抗体的原理证明。
背景:麻疹减毒病毒(OMV)在早期临床试验中是一种很有前景的抗肿瘤药物。然而,预先存在的麻疹免疫可能是OMV治疗的障碍。方法:采用短波紫外光灭活OMV。用Vero细胞进行组织培养感染剂量50 (TCID50)测定,用Jurkat细胞进行流式细胞术测定,证实了uv灭活的OMV具有复制丧失和溶瘤活性。酶联免疫吸附试验验证了紫外线灭活的OMV仍然具有抗原性。在添加麻疹免疫血清的培养基中预培养不同剂量的uv灭活OMV。将混合物转移到Jurkat细胞中,加入活性OMV。流式细胞术检测omv诱导的Jurkat细胞活性死亡。结果:紫外线灭活可抑制OMV的复制,同时保持其抗原性。紫外线灭活的OMV在Jurkat细胞培养中隔离预先存在的抗mv抗体,从而保护活性的OMV不被中和并保持溶瘤活性。结论:我们证明了不复制的OMV可以作为中和抗mv抗体的“诱饵”,从而使OMV具有抗肿瘤活性的原理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信